Products & Services · Total revenues
Other license programs — Total revenues
Alnylam Pharmaceuticals Other license programs — Total revenues increased by 439.7% to $39.7M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 198.0%, from $13.32M to $39.7M. Over 2 years (FY 2023 to FY 2025), Other license programs — Total revenues shows an upward trend with a 34.1% CAGR.
Analysis
Metric ID:
alny_segment_other_license_programs_total_revenuesHistorical Data
13 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.99M | $6.99M | $6.99M | $6.99M | $9.66M | $3.11M | $18.45M | $1.92M | $13.32M | $19.59M | $10M | $7.36M | $39.7M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +38.2% | -67.8% | +493.4% | -89.6% | +594.3% | +47.0% | -48.9% | -26.5% | +439.7% |
| YoY Change | — | — | — | — | +38.2% | -55.5% | +163.8% | -72.6% | +37.9% | +529.9% | -45.8% | +283.3% | +198.0% |
Range$1.92M – $39.7M
CAGR+78.4%
Avg YoY Growth+119.7%
Median YoY Growth+38.2%
Frequently Asked Questions
- What is Alnylam Pharmaceuticals's other license programs — total revenues?
- Alnylam Pharmaceuticals (ALNY) reported other license programs — total revenues of $39.7M in Q1 2026.
- How has Alnylam Pharmaceuticals's other license programs — total revenues changed year-over-year?
- Alnylam Pharmaceuticals's other license programs — total revenues increased by 198.0% year-over-year, from $13.32M to $39.7M.
- What is the long-term trend for Alnylam Pharmaceuticals's other license programs — total revenues?
- Over 2 years (2023 to 2025), Alnylam Pharmaceuticals's other license programs — total revenues has grown at a 34.1% compound annual growth rate (CAGR), from $27.97M to $50.27M.